Todd Koch Joins InClinica as Global Trial Manager
PHILADELPHIA (May 9, 2018) – InClinica, a global clinical CRO, announced today that Todd Koch has been appointed Global Trial Manager. In his new role, Koch will be responsible for the day-to-day leadership and management of clinical trials.
“Todd’s experience in managing clinical trial protocols and conducting global studies will be incredibly valuable to our clients as they navigate the regulatory process,” said James Nolan, CEO at InClinica. “We are thrilled to welcome him to the team.”
Koch has more than 26 years of experience in the pharmaceutical industry, with deep knowledge of clinical research and the drug development process. Prior to joining InClinica, Koch served as Senior Clinical Project Manager at Luitpold Pharmaceuticals Inc., where he was responsible for designing, writing and conducting clinical protocols for Phase I to IV clinical trials. During his 15 years at the company, Koch held various positions before advancing to Senior Clinical Project Manager, including Clinical Project Manager and Clinical Research Associate.
Koch received his bachelor’s degree, magna cum laude, in animal science from Delaware Valley College. He is an ACRP Certified Clinical Research Associate (CCRA).
Koch was formerly a member of the Pennsylvania Army National Guard.
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in the U.K., Israel, and Malaysia/Singapore.